Related references
Note: Only part of the references are listed.Hypoxia-inducible factor-1 target genes as indicators of tumor vessel response to vascular endothelial growth factor inhibition
Duyen T. Dang et al.
CANCER RESEARCH (2008)
HSP27 regulates cell adhesion and invasion via modulation of focal adhesion kinase and MMP-2 expression
Joong-Won Lee et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2008)
α2β1 integrin expression in the tumor microenvironment enhances tumor angiogenesis in a tumor cell-specific manner
Zhonghua Zhang et al.
BLOOD (2008)
beta 1 integrin expression on endothelial cells is required for angiogenesis but not for vasculogenesis
Harikrishna Tanjore et al.
DEVELOPMENTAL DYNAMICS (2008)
Multiple cardiovascular defects caused by the absence of alternatively spliced segments of fibronectin
Sophie Astrof et al.
DEVELOPMENTAL BIOLOGY (2007)
Angiogenesis inhibition and choroidal neovascularization suppression by sustained delivery of an integrin antagonist, EMD478761
Yingli Fu et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2007)
The role of integrin as α5β1 in the regulation of corneal neovascularization
Philipp S. Muether et al.
EXPERIMENTAL EYE RESEARCH (2007)
Inhibition of inflammatory lymphangiogenesis by integrin α5 blockade
Tina Dietrich et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Elevated expression of VEGFR-3 in lymphatic endothelial cells from lymphangiomas
Susanne Norgall et al.
BMC CANCER (2007)
A phase I trial of sorafenib (BAY 43-9006) for patients with recurrent or progressive malignant glioma (NABTT 0401)
L. B. Nabors et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Myeloid cell trafficking and tumor angiogenesis
Michael C. Schmid et al.
CANCER LETTERS (2007)
Integrin α9β1 directly binds to vascular endothelial growth factor (VEGF)- a and contributes to VEGF-A-induced angiogenesis
Nicholas E. Vlahakis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Interaction of α9β1 integrin with thrombospondin-1 promotes angiogenesis
Izabela Staniszewska et al.
CIRCULATION RESEARCH (2007)
Phase I and correlative biology study of cilengitide in patients with recurrent malignant glioma
L. Burt Nabors et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Phase I evaluation of a fully human anti-αv integrin monoclonal antibody (CNTO 95) in patients with advanced solid tumors
Saifee A. Mullamitha et al.
CLINICAL CANCER RESEARCH (2007)
Cooperation between VEGF and β3 integrin during cardiac vascular development
Sara M. Weis et al.
BLOOD (2007)
Effects of a monoclonal anti-αvβ3 integrin antibody on blood vessels -: A pharmacodynamic study
Dahua Zhang et al.
INVESTIGATIONAL NEW DRUGS (2007)
Vandetanib (ZD6474): an orally available receptor tyrosine kinase inhibitor that selectively targets pathways critical for tumor growth and angiogenesis
Roy S. Herbst et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
Activation of FAK/Pl3K/Rac1 signaling controls actin reorganization and inhibits cell motility in human cancer cells
Galatea Kallergi et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2007)
Integrin regulation by vascular endothelial growth factor in human brain microvascular endothelial cells -: Role of α6β1 integrin in angiogenesis
Tae-Hee Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer
Helmut Friess et al.
BMC CANCER (2006)
Integrin signaling is critical for pathological angiogenesis
Ganapati H. Mahabeleshwar et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Integrin-regulated FAK-Src signaling in normal and cancer cells
Satyajit K. Mitra et al.
CURRENT OPINION IN CELL BIOLOGY (2006)
Imaging of cell migration
Dirk Dormann et al.
EMBO JOURNAL (2006)
Phase II evaluations of cilengitide in asymptomatic patients with androgen-independent prostate cancer: Scientific rationale and study design
Kathleen W. Beekman et al.
CLINICAL GENITOURINARY CANCER (2006)
Lymphangiogenesis in development and human disease
K Alitalo et al.
NATURE (2005)
Angiogenesis in life, disease and medicine
P Carmeliet
NATURE (2005)
Phase I trial of a monoclonal antibody specific for αvβ3 integrin (MEDI-522) in patients with advanced malignancies, including an assessment of effect on tumor perfusion
DG McNeel et al.
CLINICAL CANCER RESEARCH (2005)
Integrin α4β1-VCAM-1-mediated adhesion between endothelial and mural cells is required for blood vessel maturation
B Garmy-Susini et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Incidence and risk of arm oedema following treatment for breast cancer: a three-year follow-up study
B Clark et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2005)
VEGF-A promotes tissue repair-associated lymphatic vessel formation via VEGFR-2 and the α1β1 and α2β1 integrins
YK Hong et al.
FASEB JOURNAL (2004)
Matrix-specific activation of Src and Rho initiates capillary morphogenesis of endothelial cells
YQ Liu et al.
FASEB JOURNAL (2004)
Integrins: roles in cancer development and as treatment targets
H Jin et al.
BRITISH JOURNAL OF CANCER (2004)
The homeobox transcription factor Hox D3 promotes integrin α5β1 expression and function during angiogenesis
NJ Boudreau et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Elevated Flk1 (vascular endothelial growth factor receptor 2) signaling mediates enhanced angiogenesis in β3-integrin-deficient mice
AR Reynolds et al.
CANCER RESEARCH (2004)
Dual functional roles of Tie-2/angiopoietin in TNF-α-mediated angiogenesis
JX Chen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
CNTO 95, a fully human monoclonal antibody that inhibits αv integrins, has antitumor and antiangiogenic activity in vivo
M Trikha et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Integrin β4 signaling promotes tumor angiogenesis
SN Nikolopoulos et al.
CANCER CELL (2004)
Angiogenesis in collagen I requires α2β1 ligation of a GFP* GER sequence and possibly p38 MAPK activation and focal adhesion disassembly
SM Sweeney et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Inhibition of integrin α5β1 function with a small peptide (ATN-161) plus continuous 5-FU infusion reduces colorectal liver metastases and improves survival in mice
O Stoeltzing et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Collagen I initiates endothelial cell morphogenesis by inducing actin polymerization through suppression of cyclic AMP and protein kinase A
MC Whelan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Tumor angiogenesis and accessibility: Role of vascular endothelial growth factor
RK Jain
SEMINARS IN ONCOLOGY (2002)
Lymphedema and quality of life in survivors of early-stage breast cancer
SM Beaulac et al.
ARCHIVES OF SURGERY (2002)
Integrins: Bidirectional, allosteric signaling machines
RO Hynes
CELL (2002)
Developmental regulation of β1 integrins during angiogenesis in the central nervous system
R Milner et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2002)
The EIIIA segment of fibronectin is a ligand for integrins α9β1 and α4β1 providing a novel mechanism for regulating cell adhesion by alternative splicing
YF Liao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Low plasma levels of matrix metalloproteinase 9 permit increased tumor angiogenesis
A Pozzi et al.
ONCOGENE (2002)
The alpha(1)beta(1) and alpha(2)beta(1) Integrins provide critical support for vascular endothelial growth factor signaling, endothelial cell migration, and tumor angiogenesis
DR Senger et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Enhanced pathological angiogenesis in mice lacking beta(3) integrin or beta(3) and beta(5) integrins
LE Reynolds et al.
NATURE MEDICINE (2002)
Tyrosine phosphorylation of the β4 integrin cytoplasmic domain mediates Shc signaling to extracellular signal-regulated kinase and antagonizes formation of hemidesmosomes
M Dans et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Angiogenesis in wound healing
MG Tonnesen et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS (2000)
Inhibitory effects of MLDG-containing heterodimeric disintegrins reveal distinct structural requirements for interaction of the integrin α9ß1 with VCAM-1, tenascin-C, and osteopontin
C Marcinkiewicz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Ligand binding to integrins
EF Plow et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Regulation of angiogenesis in vivo by ligation of integrin α5β1 with the central cell-binding domain of fibronectin
S Kim et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Elevated matrix metalloprotease and angiostatin levels in integrin α1 knockout mice cause reduced tumor vascularization
A Pozzi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Normal development, wound healing, and adenovirus susceptibility in β5-deficient mice
XZ Huang et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
